Summarized by Masters of Longevity from Neuroscience News.
Reports Insilico Medicine's program that uses AI to design transient circular mRNA LNP therapies to program T cells to remove early senescent and autoreactive cells in aging tissues.
Key Takeaways
- AI-Designed “Longevity Vaccines” Target the Earliest Culprits of Cellular Aging - Neuroscience News Conceptual 3D scientific visualization of an in vivo engineered T cell targeting and eliminating pro-inflammatory senescent cells, facilitated by circular RNA lipid nanoparticles.
- AI-Driven Target Discovery: Candidates are identified and prioritized using Pharma.AI foundation models and the “Virtual Aging Cell,” which map the earliest deviations in cell trajectories to find highly specific surface antigens.
- Primary Focus on Immune Rejuvenation: The first target indication addresses immunosenescence by removing accumulated senescent lymphocytes, with subsequent pipelines planned for metabolic dysfunction, fibrosis, and chronic autoimmune degeneration.
